TP53 and neoplasm: Kalmodia et al. designed AuNPs conjugated with the anti-HDM2 peptide, a peptide that inhibits the interaction between the tumor suppressor protein p53 and its negative regulator, human double minute 2 (HDM2), which degrades p53 and limits its tumor-suppressing activities.